Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more
Elevance Health Inc (ELV) - Net Assets
Latest net assets as of December 2025: $44.03 Billion USD
Based on the latest financial reports, Elevance Health Inc (ELV) has net assets worth $44.03 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($121.49 Billion) and total liabilities ($77.47 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $44.03 Billion |
| % of Total Assets | 36.24% |
| Annual Growth Rate | 12.8% |
| 5-Year Change | 21.86% |
| 10-Year Change | 75.4% |
| Growth Volatility | 50.45 |
Elevance Health Inc - Net Assets Trend (1998–2025)
This chart illustrates how Elevance Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Elevance Health Inc (1998–2025)
The table below shows the annual net assets of Elevance Health Inc from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $44.03 Billion | +6.28% |
| 2024-12-31 | $41.43 Billion | +5.13% |
| 2023-12-31 | $39.41 Billion | +8.46% |
| 2022-12-31 | $36.33 Billion | +0.56% |
| 2021-12-31 | $36.13 Billion | +8.82% |
| 2020-12-31 | $33.20 Billion | +4.64% |
| 2019-12-31 | $31.73 Billion | +11.17% |
| 2018-12-31 | $28.54 Billion | +7.69% |
| 2017-12-31 | $26.50 Billion | +5.59% |
| 2016-12-31 | $25.10 Billion | +8.92% |
| 2015-12-31 | $23.04 Billion | -4.98% |
| 2014-12-31 | $24.25 Billion | -2.08% |
| 2013-12-31 | $24.77 Billion | +4.04% |
| 2012-12-31 | $23.80 Billion | +2.21% |
| 2011-12-31 | $23.29 Billion | -2.20% |
| 2010-12-31 | $23.81 Billion | -4.23% |
| 2009-12-31 | $24.86 Billion | +16.01% |
| 2008-12-31 | $21.43 Billion | -6.78% |
| 2007-12-31 | $22.99 Billion | -6.45% |
| 2006-12-31 | $24.58 Billion | -1.67% |
| 2005-12-31 | $24.99 Billion | +28.44% |
| 2004-12-31 | $19.46 Billion | +224.32% |
| 2003-12-31 | $6.00 Billion | +11.89% |
| 2002-12-31 | $5.36 Billion | +160.31% |
| 2001-12-31 | $2.06 Billion | +7.30% |
| 2000-12-31 | $1.92 Billion | +15.59% |
| 1999-12-31 | $1.66 Billion | -2.44% |
| 1998-12-31 | $1.70 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Elevance Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3539300000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $35.39 Billion | 80.65% |
| Common Stock | $2.00 Million | 0.00% |
| Other Comprehensive Income | $-451.00 Million | -1.03% |
| Other Components | $8.94 Billion | 20.37% |
| Total Equity | $43.88 Billion | 100.00% |
Elevance Health Inc Competitors by Market Cap
The table below lists competitors of Elevance Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Meituan
PINK:MPNGF
|
$64.21 Billion |
|
Nike Inc
NYSE:NKE
|
$64.28 Billion |
|
Kinder Morgan Inc
NYSE:KMI
|
$64.50 Billion |
|
Phillips 66
NYSE:PSX
|
$64.57 Billion |
|
CSL Limited
PINK:CMXHF
|
$63.46 Billion |
|
Intel Corp. CEDEAR
BA:INTC
|
$63.23 Billion |
|
DoorDash, Inc. Class A Common Stock
NASDAQ:DASH
|
$63.10 Billion |
|
TC Energy Corp
NYSE:TRP
|
$62.83 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elevance Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 41,315,000,000 to 43,882,000,000, a change of 2,567,000,000 (6.2%).
- Net income of 5,662,000,000 contributed positively to equity growth.
- Dividend payments of 1,529,000,000 reduced retained earnings.
- Share repurchases of 2,605,000,000 reduced equity.
- Other comprehensive income increased equity by 696,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $5.66 Billion | +12.9% |
| Dividends Paid | $1.53 Billion | -3.48% |
| Share Repurchases | $2.60 Billion | -5.94% |
| Other Comprehensive Income | $696.00 Million | +1.59% |
| Other Changes | $343.00 Million | +0.78% |
| Total Change | $- | 6.21% |
Book Value vs Market Value Analysis
This analysis compares Elevance Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.49x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 35.82x to 1.49x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $8.26 | $295.75 | x |
| 1999-12-31 | $8.06 | $295.75 | x |
| 2000-12-31 | $9.31 | $295.75 | x |
| 2001-12-31 | $9.93 | $295.75 | x |
| 2002-12-31 | $22.07 | $295.75 | x |
| 2003-12-31 | $21.15 | $295.75 | x |
| 2004-12-31 | $68.12 | $295.75 | x |
| 2005-12-31 | $39.97 | $295.75 | x |
| 2006-12-31 | $38.27 | $295.75 | x |
| 2007-12-31 | $38.19 | $295.75 | x |
| 2008-12-31 | $40.88 | $295.75 | x |
| 2009-12-31 | $51.46 | $295.75 | x |
| 2010-12-31 | $57.27 | $295.75 | x |
| 2011-12-31 | $63.79 | $295.75 | x |
| 2012-12-31 | $73.28 | $295.75 | x |
| 2013-12-31 | $81.52 | $295.75 | x |
| 2014-12-31 | $84.82 | $295.75 | x |
| 2015-12-31 | $84.44 | $295.75 | x |
| 2016-12-31 | $93.62 | $295.75 | x |
| 2017-12-31 | $98.97 | $295.75 | x |
| 2018-12-31 | $112.23 | $295.75 | x |
| 2019-12-31 | $121.89 | $295.75 | x |
| 2020-12-31 | $130.55 | $295.75 | x |
| 2021-12-31 | $146.11 | $295.75 | x |
| 2022-12-31 | $149.27 | $295.75 | x |
| 2023-12-31 | $165.57 | $295.75 | x |
| 2024-12-31 | $177.39 | $295.75 | x |
| 2025-12-31 | $197.84 | $295.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Elevance Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.90%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.84%
- • Asset Turnover: 1.64x
- • Equity Multiplier: 2.77x
- Recent ROE (12.90%) is above the historical average (12.37%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 10.13% | 1.56% | 2.54x | 2.56x | $2.15 Million |
| 1999 | 2.70% | 0.36% | 2.56x | 2.90x | $-121.19 Million |
| 2000 | 11.77% | 1.31% | 3.03x | 2.97x | $34.02 Million |
| 2001 | 16.61% | 3.28% | 1.65x | 3.08x | $136.20 Million |
| 2002 | 10.24% | 4.14% | 1.07x | 2.32x | $12.87 Million |
| 2003 | 12.91% | 4.62% | 1.25x | 2.23x | $174.31 Million |
| 2004 | 4.93% | 4.61% | 0.51x | 2.09x | $-985.80 Million |
| 2005 | 9.86% | 5.46% | 0.88x | 2.06x | $-35.51 Million |
| 2006 | 12.59% | 5.43% | 1.10x | 2.11x | $637.32 Million |
| 2007 | 14.55% | 5.45% | 1.18x | 2.26x | $1.05 Billion |
| 2008 | 11.62% | 3.99% | 1.29x | 2.26x | $347.53 Million |
| 2009 | 19.09% | 7.70% | 1.18x | 2.10x | $2.26 Billion |
| 2010 | 12.12% | 4.91% | 1.15x | 2.15x | $505.84 Million |
| 2011 | 11.36% | 4.35% | 1.14x | 2.29x | $317.88 Million |
| 2012 | 11.16% | 4.32% | 1.02x | 2.53x | $275.23 Million |
| 2013 | 10.72% | 3.73% | 1.18x | 2.44x | $177.68 Million |
| 2014 | 10.60% | 3.48% | 1.17x | 2.59x | $144.57 Million |
| 2015 | 11.11% | 3.23% | 1.26x | 2.74x | $255.59 Million |
| 2016 | 9.84% | 2.91% | 1.28x | 2.64x | $-40.24 Million |
| 2017 | 14.50% | 4.27% | 1.26x | 2.70x | $1.19 Billion |
| 2018 | 13.14% | 4.07% | 1.27x | 2.54x | $895.90 Million |
| 2019 | 15.15% | 4.61% | 1.33x | 2.47x | $1.63 Billion |
| 2020 | 13.77% | 3.75% | 1.38x | 2.66x | $1.25 Billion |
| 2021 | 16.93% | 4.40% | 1.42x | 2.70x | $2.50 Billion |
| 2022 | 16.26% | 3.76% | 1.52x | 2.84x | $2.27 Billion |
| 2023 | 15.23% | 3.49% | 1.57x | 2.77x | $2.06 Billion |
| 2024 | 14.47% | 3.38% | 1.51x | 2.83x | $1.85 Billion |
| 2025 | 12.90% | 2.84% | 1.64x | 2.77x | $1.27 Billion |
Industry Comparison
This section compares Elevance Health Inc's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $6,637,605,834
- Average return on equity (ROE) among peers: -6.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Elevance Health Inc (ELV) | $44.03 Billion | 10.13% | 1.76x | $63.54 Billion |
| Alignment Healthcare LLC (ALHC) | $239.30 Million | -62.49% | 1.65x | $3.04 Billion |
| Cigna Corp (CI) | $41.24 Billion | 8.33% | 2.78x | $71.15 Billion |
| Clover Health Investments Corp (CLOV) | $-17.63K | 0.00% | 0.00x | $788.86 Million |
| Centene Corp (CNC) | $326.42 Million | -13.37% | 1.74x | $17.10 Billion |
| CarePayment Technologies Inc (CPYT) | $6.95 Million | -32.50% | 0.49x | $2.47K |
| CVS Health Corp (CVS) | $1.10 Billion | 19.07% | 0.64x | $94.98 Billion |
| Humana Inc (HUM) | $16.10 Billion | 18.21% | 1.75x | $20.50 Billion |
| Interact Holdings Group Inc (IHGP) | $-1.46 Million | 0.00% | 0.00x | $335.63 |
| Molina Healthcare Inc (MOH) | $719.06 Million | 7.64% | 1.10x | $6.97 Billion |